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Abstract 
Background. There are few data on differences in exposure to risk factors for coronary heart 
disease (CHD) in relation to geographic areas, especially areas with large differences in terms 
of continental and Mediterranean climates. To study these differences in Croatia, we analyzed 
data from the Treatment and Secondary Prevention of Ischemic Coronary Events in Croatia V 
(TASPIC-CRO V) study, which recruited Croatian CHD patients in two principal regions 
(Mediterranean and continental) of the country. 
Methods. A total of 31 Croatian research centers participated in the study. We collected 
information on personal details, demographic characteristics and risk factor exposure from the 
hospital medical records of 3054 CHD patients. Risk factors included history of cigarette 
smoking, hypertension, hyperlipidemia (total cholesterol, triglycerides, HDL-cholesterol and 
LDL-cholesterol) and diabetes type II. 
Results. Both univariate and multivariate analyses showed that the prevalence of 
hypertension in examined CHD patients was significantly higher in the continental part of 
Croatia than in the Mediterranean part (univariate analysis: P <0.001; multivariate analysis: 
P=0.003). Multivariate analysis revealed a higher prevalence of decreased HDL-cholesterol in 
continental Croatia (P=0.006) and a higher prevalence of smokers in coastal Mediterranean 
Croatia (P=0.007). A significant difference in total cholesterol levels was noted between 
hospitalized CHD patients in two Mediterranean subregions (P<0.001). No significant 
differences between continental and coastal Mediterranean parts of Croatia were found for 
other CHD risk factors. 
Conclusions. Higher prevalences of both hypertension and decreased HDL-cholesterol were 
recorded in hospitalized CHD patients in the continental part of Croatia, but in coastal 
Mediterranean Croatia there was higher prevalence of smokers. Differences in total 
cholesterol, LDL-cholesterol and triglycerides between hospitalized CHD patients in 
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continental and coastal Mediterranean Croatia did not follow the expected continental–
Mediterranean pattern. 
Key words: coronary heart disease, cardiovascular risk factors, diet, Mediterranean life style, 
hypertension, cholesterol 
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Introduction 
Recent data for Croatia show that cardiovascular diseases caused 52.8% of all deaths in 2003 
[1]. This classifies Croatia among the European countries with very high rates of mortality 
from cardiovascular disease [2]. Risk factors for ischemic heart disease, the most frequent 
form of cardiovascular disease, are widely recognized: they include lifestyle, habits, diet, 
environment, and genetic and other factors [3–5]. 
Studies conducted more than four decades ago showed that Mediterranean countries have 
lower mortality from cardiovascular diseases than continental countries [4]. The observed 
differences were explained by the lifestyles and diet in Mediterranean regions in comparison 
with other European regions [4, 6–17]. 
However, in more recent literature, the true extent of the effect of Mediterranean lifestyle and 
diet on the development of cardiovascular disease is more controversial. Most of the studies 
have shown that regional and lifestyle differences can have dramatic effects on development 
of cardiovascular disease [6–9, 18] and, in particular, the beneficial effects of a Mediterranean 
diet rich in vegetables, olive oil and fish, as well as the lifestyle, are especially highlighted 
[10–17, 19–21]; other authors, however, dispute these findings [22]. 
Croatia’s history, climate and geographical shape provide an excellent example of a country 
with significant differences between its continental and Mediterranean parts, thus presenting a 
unique opportunity to study differences in the population, particularly at the subregion level. 
This report explores differences in exposure to risk factors for coronary heart disease (CHD) 
in two principal regions of Croatia, continental and Mediterranean, by analyzing data from a 
study of CHD patients —the Treatment and Secondary Prevention of Ischemic Coronary 
Events in Croatia V (TASPIC-CRO V) study. The aim of our analysis was to resolve some of 
the controversies related to differences between Mediterranean and other parts of Europe in 
mortality rates for ischemic heart disease. 
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Materials and methods 
A total of 31 research centers (7 university hospitals, 24 general hospitals) spanning the entire 
geographical area of Croatia took part in the TASPIC-CRO V study. Investigators in the 
research centers were asked to report consecutive patients of both sexes with the following 
diagnoses: acute myocardial infarction (Q and non-Q), angina pectoris (stable and non-stable) 
and post-infarction angina pectoris (stable and non-stable). Sources of data were diagnostic 
registers, patients' records, hospital discharge lists and other medical documents. The criteria 
for diagnosis and procedures were similar to those described in EUROASPIRE II [23] and 
TASPIC-CRO I-V [24].  
Using the above criteria, we analyzed data from 3054 patients in TASPIC-CRO V who were 
consecutively hospitalized between September 30th 2002 and March 31st 2003. A 
modification to the EUROASPIRE methodology was used, permitting recruitment of patients 
over the age of 70. We divided the research centers into two main categories: continental (4 
university hospitals, 19 general hospitals) and coastal Mediterranean (3 university hospitals, 5 
general hospitals); these were further divided into traditional geographic regions: City of 
Zagreb, Central Croatia, Northern Croatia and Slavonia as parts of continental Croatia and 
Primorje/Istria and Dalmatia as parts of coastal Mediterranean Croatia (Fig. 1). 
The data were collected from the patients' hospital medical records for any time prior to the 
date of acute hospital admission or procedure, and at the discharge. Data included personal 
and demographic details, together with risk factors: history of cigarette smoking, 
hypertension, hyperlipidemia (total cholesterol, triglycerides, HDL-cholesterol, LDL-
cholesterol) and diabetes type II [3–5]. All the equipment used was standardized for use in 
daily clinical work with patients, with certificates from the State Office for Metrology; all 
laboratories in Croatia have certificates of quality issued by the Ministry of Health, thus 
ensuring standardized measuring of biochemical variables. All blood samples were fasting 
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and drawn during first 24 hours of admission to the hospital. The research centers recorded 
risk factors in uniform predefined ways, with criteria valid in 2003 according to the guidelines 
in use in everyday clinical practice at that time. Hypertension was defined as all values of RR 
≥140 mmHg systolic and ≥90 mmHg diastolic. Total cholesterol >5.00 mmol/l and LDL-
cholesterol >3.00 mmol/l (Friedewald equation) were considered elevated, HDL-cholesterol 
<1.00 mmol/l was considered lowered and triglycerides >2.00 mmol/l were considered 
elevated. Diabetes was diagnosed if the fasting plasma glucose level was ≥7.0 mmol/l, or 
≥11.1 mmol/l at any other time. 
 
Statistical analysis 
Statistical methods used in this analysis were cross-tabulations of 2x2 contingency tables 
analyzed using Fisher’s exact test. For higher order contingency tables, the χ2 test with the 
Monte Carlo test of statistical significance was used. Binary logistic regression analysis was 
used to produce unadjusted and adjusted odds ratios, which indicated the likelihood of living 
in the coastal Mediterranean region for respondents with certain characteristics relative to the 
reference group (those living in the continental region). P levels of 0.05 or less were accepted 
as statistically significant. 
 
Informed consent was obtained from every patient and the study protocol conformed to the 
ethical guidelines of the 1975 Declaration of Helsinki. 
 
Results 
A total of 3054 patients were recruited: 1969 (64.5%) in the continental region of Croatia and 
1085 (35.5%) in the coastal Mediterranean region (Table 1). The mean age was 64.2±11.3 
years (range 23–102). Analysis of relation of age to sex showed that 63.9% of the patients 
were men (mean age 61.7±11.2 years) and 36.1% women (mean age 68.5±10.1 years), the 
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difference being significant (P <0.001). The difference in mean age of patients in the 
continental and Mediterranean parts was not significant (P=0.387). 
Analysis of diagnoses by region (continental and coastal) showed more Q-wave myocardial 
infarctions in the coastal region than in the continental region, but this reached only borderline 
significance (41.1% and 37.5%, P=0.052). Unstable angina and stable post-infarction angina 
were significantly more frequent in the continental region than in the coastal region (16.2% 
and 12.4%, P=0.007; 6.0% and 3.7%, P=0.006). 
Regional and subregional distribution of risk factors were analyzed (Table 2). Regional 
differences showed significantly more hypertension in the continental region (72.4% and 
62.1%, P <0.001) and also a borderline significance of lower HDL-cholesterol values (37.9% 
and 33.8%, P=0.071). At the subregion level, there were significant differences in frequency 
of elevated total cholesterol (53.4% of patients in Primorje/Istria; 79.5% in Slavonia, P 
<0.001), elevated LDL-cholesterol (54.7% of patients in Primorje/Istria; 79.7% in Slavonia, P 
<0.001), elevated triglycerides (28.8% of patients in Primorje/Istria; 43.1% in Dalmatia, P 
<0.001) and presence of hypertension (61.8% of patients in Primorje/Istria; 79.1% in 
Central Croatia, P <0.001). 
In analysis by traditional region (Table 2), prevalences of diabetes (ranging from 29.2% 
in Slavonia to 34.5% in Central Croatia) and smoking (ranging from 29.8% in the City 
of Zagreb to 36.4% in Northern Croatia) did not show any significant differences 
(P=0.385 and P=0.133). There was significant difference in prevalence of hypertension 
(P<0.001) in hospitalized CHD patients, with Slavonia (61.9%), Primorje/Istria (61.8%) 
and Dalmatia (62.5%) having the lowest prevalence, and Central Croatia (79.1%) 
having the highest. 
Table 3 shows mean values for four risk factors (total cholesterol, LDL-cholesterol, HDL-
cholesterol and triglycerides), comparing regional and subregional differences.  
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Total cholesterol levels were highest in Slavonia (average 6.08±1.37 mmol/l), Dalmatia 
(5.95±1.33 mmol/l), Central Croatia (5.78±1.36 mmol/l), the City of Zagreb (5.58±1.41 
mmol/l) and Northern Croatia (5.56±1.31 mmol/l) and lowest in Primorje/Istria (5.28±1.25 
mmol/l), with these differences being statistically significant (P <0.001). Pairwise 
comparisons of total cholesterol by region (with Bonferroni correction), showed that levels in 
the City of Zagreb were significantly lower than in Dalmatia (P <0.001) but significantly 
higher than in Primorje/Istria (P=0.002), levels in Central Croatia were significantly higher 
than in Primorje/Istria (P <0.001), levels in Northern Croatia were significantly lower than in 
Dalmatia (P <0.001) but significantly higher than in Primorje/Istria (P=0.003), and levels in 
Slavonia were significantly higher than in Primorje/Istria (P <0.001). 
LDL-cholesterol levels were highest in Slavonia (4.10±2.49 mmol/l), Dalmatia (3.82±1.21 
mmol/l), Central Croatia (3.80±2.41 mmol/l), City of Zagreb (3.65±2.71 mmol/l), Northern 
Croatia (3.63±1.17 mmol/l) and lowest in Primorje/Istria (3.28±0.95 mmol/l), with these 
differences being statistically significant (P <0.001). Pairwise comparisons of LDL-
cholesterol by region (with Bonferroni correction) showed that levels were borderline 
significantly higher in Central Croatia than in Primorje/Istria (P=0.067) and levels in Slavonia 
were significantly higher than in Primorje/Istria (P <0.001). 
HDL-cholesterol levels were lowest in Primorje/Istria (1.09±0.58 mmol/l), Central Croatia 
(1.17±0.36 mmol/l), City of Zagreb (1.17±0.53 mmol/l), Northern Croatia (1.18±0.49 
mmol/l), Dalmatia (1.21±0.35 mmol/l) and highest in Slavonia (1.25±0.42 mmol/l), with these 
differences being statistically significant (P=0.008). Pairwise comparisons of HDL-
cholesterol by region (with Bonferroni correction) showed that levels were significantly lower 
in Primorje/Istria than in Slavonia (P=0.005). 
Trigycerides levels by region were highest in Dalmatia (2.16±1.65 mmol/l), Central Croatia 
(2.15±1.44 mmol/l), City of Zagreb (2.09±1.64 mmol/l), Slavonia (2.06±1.24 mmol/l), 
Primorje/Istria (1.90±1.32 mmol/l) and lowest in Northern Croatia (1.83±1.30 mmol/l), with 
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these differences being statistically significant (P<0.001). Pairwise comparisons of 
triglycerides by region (with Bonferroni correction) showed that levels were significantly 
lower in Northern Croatia than in Dalmatia (P<0.001). 
As shown in Table 4, decreased HDL-cholesterol, hypertension, smoking and the patient's sex 
are risk factors that significantly change the odds for patients to live in the coastal region. 
Thus, patients with hypertension have 27% smaller odds for living in coastal Croatia (OR 
0.73, CI 0.59–0.89, P=0.003) than non-hypertensive patients; patients with decreased HDL-
cholesterol have 26% smaller odds (OR 0.74, CI=0.60–0.92, P=0.006) than patients with 
normal HDL-cholesterol; patients who smoke have 33% higher odds (OR 1.33, CI=1.08–1.64, 
P=0.007) than non-smokers; and female CHD patients have 25% smaller odds (OR 0.75, 
CI=0.60–0.93, P=0.009) than male CHD patients.  
 
Discussion 
The TASPIC-CRO V study, which recruited and investigated hospitalized CHD patients, 
showed that the prevalences of most cardiovascular risk factors do not differ between the 
continental and Mediterranean areas of Croatia. Using simple univariate analysis we showed 
that in TASPIC-CRO V the only significant difference between these two parts of Croatia was 
the higher prevalence of hypertension in the continental part. In addition, the use of 
multivariate analysis showed that patients with hypertension have 27% smaller odds for living 
in costal-Mediterranean Croatia.  
As Croatia’s continental part could be considered as “north” and its coastal-Mediterranean 
part “south”, it is interesting to compare our results with those of a similar study published in 
1998 by Park et al [9]. They investigated geographic differences in the characteristics of 
coronary artery disease in India and found a lower frequency of unstable angina in the south 
(coastal part) of India (the opposite from what we observed) and a higher prevalence of 
hypertension in northern (continental) India (which is in accordance with our results).  
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It is well known that morbidity and mortality from cardiovascular diseases are much lower in 
the countries of the Mediterranean region than in continental parts of Europe [25]. 
Cardiovascular mortality rates (both male and female) in Croatia seem to show a similar 
pattern in 2003: these were highest for Northern Croatia and Slavonia (continental part), and 
lowest for Dalmatia and Primorje/Istria (Mediterranean part), with rates for Central Croatia 
and City of Zagreb lying in between [1]. 
The majority of the literature, corroborated by general public consensus, claims that the 
reasons for lower rates of ischemic heart disease and cardiovascular disease mortality in 
Mediterranean regions in relation to other parts of Europe lie in different prevalences and 
incidences of risk factors for those diseases and different lifestyles and habits [4, 13, 15]. 
In our study, analysis of the prevalence of elevated total cholesterol levels in hospitalized 
CHD patients in traditional geographic regions of Croatia showed the lowest prevalence in the 
coastal subregion Primorje/Istria (53.4%). This could be expected if one assumes that coastal 
parts of Croatia are characterized by Mediterranean diet. However, the difference between the 
two coastal subregions Primorje/Istria and Dalmatia in patients' total cholesterol levels was 
found to be significant, with higher levels measured in Dalmatia (P <0.001). The reason for 
the difference between these two Mediterranean parts of Croatia remains unclear. 
Based on currently available research data, three possible explanations for the observed 
differences in cardiovascular risk factors in hospitalized CHD patients can be offered. One is 
based upon the effects of war (1991–1995) and postwar stress in Croatia on acute and chronic 
CHD [26, 27], and the influence of war and the post-war period on the changes throughout the 
country of traditional lifestyles of people who developed CHD. The second explanation could 
be the extensive migrations of the population during the war and the post-war period; these 
caused dramatic differences in the habits, diets and lifestyles of the migrated populations 
compared with the traditional lifestyles in each region [28]. If this is the case, exposure to 
stress, social deprivation and unhealthy lifestyles might have overcome any possible 
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protective effects of the Mediterranean diet and lifestyle in patients affected with CHD. The 
third explanation could be that for some reason the diet has changed in at least one of these 
two traditional Croatian geographic regions; for example, a trend toward consumption of 'fast 
food' and an increase in consumption of animal fat from dairy products [29, 30]. In this 
context it is also interesting to note that multivariate analysis showed that patients with 
decreased HDL-cholesterol have 26% smaller odds for living in coastal-Mediterranean 
Croatia, but at the same time patients who smoke have 33% higher odds. Although the odds 
for decreased HDL-cholesterol could be explained by Mediterranean diet (although it is not 
clear why this beneficial effect is not observed in other lipid variables investigated), it is 
difficult to explain why patients who smoke have higher odds of living in coastal Croatia. The 
common characteristic of all the mentioned confounding factors is that currently there are 
insufficient data to allow exact quantification of the influence of each one on cardiovascular 
risk factors. Research projects currently underway in Croatia offer hope that quantification for 
some of the confounding factors will soon be possible. 
Analysis of mean levels of total cholesterol in hospitalized CHD patients in traditional 
geographic regions showed that mean levels were lowest in Primorje/Istria (5.28±1.25 
mmol/l) and highest in Slavonia (6.08±1.37 mmol/l), but nevertheless above an acceptable 5.0 
mmol/l everywhere. This was not a completely unexpected finding, because this survey 
examined a population of hospitalized CHD patients who would be expected to have one or 
more cardiovascular risk factors. However, the fact that there are such profound differences 
between traditional geographic regions in prevalence and occurrence of cardiovascular risk 
factors requires further analysis. 
The prevalence of elevated LDL-cholesterol in hospitalized CHD patients in different 
traditional regions followed the same pattern as that for total cholesterol, again with the 
lowest mean levels of LDL-cholesterol (Primorje/Istria, 3.28±0.95 mmol/l) being above 
acceptable levels.  
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Analysis of the prevalence of decreased HDL-cholesterol in hospitalized CHD patients 
showed a somewhat different pattern: the highest prevalence was in Northern Croatia (39.3%) 
and the lowest in Dalmatia (32.2%). But when we analyzed the mean levels of HDL-
cholesterol, a pattern identical to those described for mean levels of total cholesterol and 
LDL-cholesterol was found: the lowest mean levels of HDL-cholesterol were measured in 
Primorje/Istria (1.09±0.58 mmol/l) and the highest in Slavonia (1.25±0.42 mmol/l). 
Multivariate analysis showed a higher prevalence of decreased HDL-cholesterol in 
continental Croatia than in coastal-Mediterranean Croatia (P=0.006). 
The inconsistency became even greater when we analyzed the prevalence of elevated 
triglycerides in hospitalized CHD patients in traditional regions: the lowest prevalence was in 
Primorje/Istria (28.8%) and the highest in Dalmatia (43.1%), both coastal regions with 
Mediterranean diet. Only two traditional regions showed mean levels of triglycerides that 
were not elevated: Northern Croatia (1.83±1.30 mmol/l) and Primorje/Istria (1.90±1.32 
mmol/l). The highest mean level of triglycerides was in the Mediterranean region of Dalmatia 
(2.16±1.65 mmol/l), a significant difference in comparison with Primorje/Istria (P=0.045). 
Since these differences are not in line with “a priori” expectations, a question should be 
asked: are any beneficial effects of a Mediterranean lifestyle really observed in Croatia? If 
not, is it because the diet habits have changed? Apparently, this cannot be answered as there 
are no firm data to provide any information that would enable us to draw a conclusion. 
Regardless of the diet issues, the prevalence of risk factors for CHD is extremely high in 
Croatia [1, 30]. This will not lead to favorable trends in prevalence and future incidence of 
CHD unless action is taken to reduce those risks, which includes not just effective treatment 
of CHD patients but also effective prevention [31]. Furthermore, although there are 
differences between regions, they are concentrated in traditional geographic regions 
(subregions), and in most cases do not follow the expected continental-Mediterranean pattern. 
Also, in most cases there seem to be no clear beneficial effects of the Mediterranean diet; it 
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appears that there are no consistent differences between the continental and Mediterranean 
parts of Croatia in cardiovascular risk factors in the studied CHD population.  
Although in our study there were no data on education level and habitation status of the 
patients (native/immigrants), an interesting example from Austria shows the need for 
intensifying the care of less well educated people and people of non-national origin 
concerning prevention of CHD risk factors, which were higher in those groups [32]. 
We also compared our data on prevalence of risk factors in CHD patients with data from the 
First Croatian Health project, conducted on the general population almost 10 years ago (Table 
5). Results from that project found no significant differences between continental and coastal-
Mediterranean parts of Croatia concerning the majority of risk factors for cardiovascular 
diseases (smoking, hypertension, total and LDL-cholesterol, triglycerides) [29]. The most 
unexpected difference between the two studies was the lower level of total cholesterol in the 
CHD patients compared with the general population; however, taking into account the time 
difference between the two studies, the explanation may be that standards of living and 
healthcare have increased in the meanwhile and may be expected to result in lower total 
cholesterol levels. Nevertheless, this does not explain another observed difference – that CHD 
patients have higher triglyceride levels. Other differences in comparison with the general 
population include, as expected, a higher prevalence of hypertension in CHD patients and a 
higher rate of smoking in male patients, but also, surprisingly, a lower rate of smoking in 
female CHD patients.  
In the context of these differences, one should bear in mind that for several reasons it is very 
difficult to compare these two surveyed populations, and Table 5 is presented to show 
approximate comparisons only for the purpose of giving a clearer picture of the available data 
on this topic in Croatia. One of the main difficulties is that, although there have been many 
recent studies in Croatia, at present there are no universally accepted results on the exact 
prevalence of risk factors. There is only a general public consensus that the prevalence of 
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these factors is high, indicating a strong need for an evidence-based survey that would yield 
objective and universally acceptable results. In that respect, an application for a scientific 
grant has been successfully submitted to the Croatian Ministry of Science, Education and 
Sports to support a program of projects investigating these risk factors in several types of 
population: general, adolescents, hospitalized CHD patients, families of killed war soldiers, 
and patients who already have risk factors but have not developed CHD symptoms. 
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Legend to Figure 1.  
 
Republic of Croatia: surveyed research centers were divided into two principal regions 
(continental and coastal-Mediterranean) and into traditional geographic regions/subregions 
(City of Zagreb, Central Croatia, Northern Croatia and Slavonia as parts of continental 
Croatia; Primorje/Istria and Dalmatia as parts of coastal-Mediterranean Croatia) 
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Table 1. TASPIC-CRO V* study: distribution of 3054 CHD patients** by sex, mean age and 
Croatian region  
 
No. (%) of patients Mean age ± std. dev. (years)  
Total Male Female P Total Male Female P 
Continental 1969 
(64.5) 
1136 
(61.2) 
721 (38.8) < 
0.001 
64.2±11.
2 
61.5±11.
0 
68.4±10.1 < 
0.001 
Mediterran
ean 
1085 
(35.5) 
696 (68.9) 314 (31.1) <0.00
1 
64.1±11.
4 
62.1±11.
3 
68.6±10.1 <0.00
1 
Total 3054 (100) 1832 
(63.9) 
1035 
(36.1) 
<0.00
1 
64.2±11.
3 
61.7±11.
2 
68.5±10.1 <0.00
1 
 
*Treatment and Secondary Prevention of Ischemic Coronary Events in Croatia V;  
**coronary heart disease patients hospitalized between September 30th 2002 and March 31st 
2003  
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Table 2. TASPIC-CRO V* study: regional and subregional distribution of risk factors of 3054 
CHD patients**  
 
No. (%) with risk factors Contin
ental 
Mediter
ranean 
χ
2
 d
f 
P City of 
Zagre
b 
Centr
al 
Croati
a 
North
ern 
Croati
a 
Slavon
ia 
Elevated total cholesterol 
(>5.00 mmol/l) 
1257 
(65.6) 
673 
(64.7) 
0.23
8 
1 0.62
8 
384 
(63.2) 
242 
(67.8) 
457 
(62.4) 
174 
(79.5) 
Elevated LDL (>3.00 
mmol/l) 
949 
(68.7) 
460 
(67.6) 
0.22
0 
1 0.65
1 
337 
(65.1) 
118 
(68.6) 
349 
(68.4) 
145 
(79.7) 
Decreased HDL (<1.00 
mmol/l) 
579 
(37.9) 
235 
(33.8) 
3.38
6 
1 0.07
1 
218 
(39.2) 
59 
(33.9) 
241 
(39.3) 
61 
(33.0) 
Elevated triglycerides 
(>2.00 mmol/l) 
693 
(36.2) 
370 
(35.9) 
0.03
7 
1 0.87
2 
244 
(40.3) 
132 
(37.1) 
229 
(31.3) 
88 
(40.2) 
Diabetes 602 
(30.6) 
324 
(29.9) 
0.16
8 
1 0.71
1 
187 
(29.8) 
127 
(34.5) 
222 
(29.7) 
66 
(29.2) 
Hypertension 1425 
(72.4) 
674 
(62.1) 
34.2
09 
1 <0.0
01 
434 
(69.1) 
291 
(79.1) 
560 
(75.0) 
140 
(61.9) 
Smoking 657 
(33.4) 
381 
(35.1) 
0.95
3 
1 0.33
8 
187 
(29.8) 
127 
(34.5) 
272 
(36.4) 
71 
(31.4) 
 
*Treatment and Secondary Prevention of Ischemic Coronary Events in Croatia V; **coronary 
heart disease patients hospitalized between September 30th 2002 and March 31st 2003
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Table 3. TASPIC-CRO V* study: regional and subregional mean values of risk factors of 
3054 CHD patients**  
 
Mean values of risk 
factors (in mmol/l)  ± std. 
dev. 
Contine
ntal 
Mediter
ranean 
P City of 
Zagre
b 
Centr
al 
Croati
a 
North
ern 
Croati
a 
Slavon
ia 
Primo
rje 
and 
Istria 
Dalma
Total cholesterol 5.67±1.3
7 
5.61±1.3
3 
0.3
09 
5.58±1
.41 
5.78±1
.36 
5.56±1
.31 
6.08±1
.37 
5.28±1
.25 
5.95±1
P / / / <0.001 
=0.002 
 
 
<0.001 
 
 
 
<0.001 
=0.003 
 
 
 
 
 
<0.001 
 
=0.002 
<0.001 
 
=0.003 
<0.001 
<0.001
<0.001
LDL-cholesterol 3.72±2.1
9 
3.61±1.1
4 
0.2
27 
3.65±2
.71 
3.80±2
.41 
3.63±1
.17 
4.10±2
.49 
3.28±0
.95 
3.82±1
P / / /  =0.067   
<0.001 
=0.067 
<0.001 
HDL-cholesterol 1.18±0.4
9 
1.17±0.4
6 
0.3
76 
1.17±0
.53 
1.17±0
.36 
1.18±0
.49 
1.25±0
.42 
1.09±0
.58 
1.21±0
P / / /    =0.005 =0.005 
Triglycerides 2.00±1.4
4 
2.03±1.5
0 
0.5
79 
2.09±1
.64 
2.15±1
.44 
1.83±1
.30 
2.06±1
.24 
1.90±1
.32 
2.16±1
P      <0.001   <0.001
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*Treatment and Secondary Prevention of Ischemic Coronary Events in Croatia V; ** 
coronary heart disease patients hospitalized between September 30th 2002 and March 31st 
2003 
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Table 4. TASPIC-CRO V* study: binary logistic regression (univariate and multivariate, 
adjusted solution) for CVD risk factors by geographic region 
Region   
N (%)  OR (95% CI**) p† 
 
Continental Coastal Univariate 
analysis 
Multivariate 
analysis 
No 771 (40.2) 423 (40.7) 1 1 
Yes 1145 (59.8) 617 (59.3) 0.98 (0.84-1.14) 0.819 
0.90(0.68- 1.20) 
0.484 
Elevated total 
cholesterol 
(>5.00 mmol/l) Total 1916 (100.0) 1040 
(100.
0)   
        
No 433 (31.3) 220 (33.7) 1 1 
Yes 949 (68.7) 460 (32.6) 0.95 (0.78-1.16) 0.639 
0.96 (0.72-1.29) 
0.796 Elevated LDL (>3.00 mmol/l) 
Total 1382 (100.0) 680 (100.0)   
        
No 950 (62.1) 460 (66.2) 1 1 
Yes 579 (39.7) 235 (33.8) 0.84 (0.69-1.01) 0.066 
0.74 (0.60-0.92) 
0.006 Decreased HDL (<1.00 mmol/l) 
Total 1529 (100.0) 695 (100.0)   
        
No 1219 (63.8) 661 (64.1) 1 1 
Yes 693 (36.2) 370 (35.9) 0.99 (0.84-1.15) 0.847 
1.01 (0.81-1.25) 
0.943 
Elevated 
triglycerides 
(>2.00 mmol/l) Total 1912 (100.0) 1031 
(100.
0)   
        
No 1367 (69.4) 761 (70.1) 1 1 
Yes 602 (30.6) 324  (29.9) 
1.16 (0.94-1.44) 
0.161 
1.86 (0.69-1.06) 
0.161 Diabetes 
Total 1969 (100.0) 1085 
(100.
0)   
        
No 544 (27.6) 411 (37.9) 1 1 
Yes 1425 (72.4) 674 (62.1) 0.63 (0.54-0.73) 0.000 
0.73 (0.59-0.89) 
0.003 Hypertension 
Total 1969 (100.0) 1085 
(100.
0)   
 
       
No 1312 (66.6) 704 (64.9) 1 1 
Yes 657 (33.4) 381 (35.1) 1.08 (0.92-1.26) 0.329 
1.33 (1.08-1.64) 
0.007 Smoking 
Total 1969 (100.0) 1085 
(100.
0)   
 
       
Sex Male 1136 (61.2) 696 (68.9) 1 1 
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Femal
e 
721 (38.8) 314 (36.1) 0.71 (0.60-0.84) 0.000 
0.75 (0.60-0.93) 
0.009 
Total 1857 (100.0) 1010 
(100.
0)   
 
*Treatment and Secondary Prevention of Ischemic Coronary events in Croatia V; CVD 
coronary vascular disease; **Odds ratio 95% confidence interval; † OR = odds ratio; first 
category of each independent variable was the referent; continental region was the reference 
category of dependent variable  
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Table 5. Comparison of data on prevalence of CHD* risk factors in the Croatian general 
population [29] and the Croatian CHD population (3054 patients**) 
 First Croatian Health 
Project [29] 
(1995–1997) 
General population 
TASPIC-CRO V*** 
(2002–2003) 
CHD patient 
population 
Total cholesterol 
(mmol/l) 
5.74±1.33 5.65±1.35 
LDL-cholesterol (mmol/l) 3.76±1.18 3.68±1.91 
HDL-cholesterol 
(mmol/l) 
1.18±0.37 1.18±0.48 
Triglycerides (mmol/l) 1.76±1.41 2.01±1.46 
Diabetes (%) no data 30.3 
Hypertension (%) 27.7 68.7 
Smoking – males (%) 
Smoking – females (%) 
34.1 
26.6 
44.1 
17.0 
*coronary heart disease; ** hospitalized between September 30th 2002 and March 31st 2003; 
***Treatment and Secondary Prevention of Ischemic Coronary Events in Croatia V  
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Figure 1.  
 
 
 
 
 
Istria and Primorje Central 
Croatia 
Dalmatia 
Slavonia 
Northern Croatia 
City of Zagreb 
SLOVENIA 
AUSTRIA 
HUNGARY 
BOSNIA AND HERZEGOVINA 
SERBIA 
MONTENEGRO 
ALBANIA 
ITALY 
